# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
COSCIENS Biopharma (NASDAQ:CSCI) reported quarterly losses of $(0.64) per share. This is a 36.17 percent decrease over losses o...